ESLA fundamentals

An in-depth look to Estrella Immunopharma, Inc. operating, investing, and financing activities

ESLA free cash flow for Q3 25 is -465.98 k USD. For 2024, ESLA free cash flow was -16.07 M USD and operating cash flow was -16.07 M USD.

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Q3 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: USD